Belite Bio Inc (BLTE)
NASDAQ: BLTE
· Real-Time Price · USD
72.99
-1.01 (-1.36%)
At close: Oct 01, 2025, 1:51 PM
-1.36% (1D)
| Bid | 52.2 |
| Market Cap | 2.38B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -49.38M |
| EPS (ttm) | -1.55 |
| PE Ratio (ttm) | -47.09 |
| Forward PE | -46.5 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 93.58 |
| Volume | 17,576 |
| Avg. Volume (20D) | 55,339 |
| Open | 73.61 |
| Previous Close | 74.00 |
| Day's Range | 72.96 - 73.75 |
| 52-Week Range | 47.13 - 86.53 |
| Beta | -1.50 |
| Ex-Dividend Date | n/a |
About BLTE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BLTE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BLTE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+3.83%
Belite Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
8 months ago
+3.58%
Belite Bio shares are trading higher after Benchmark raised its price target on the stock from $57 to $79.
